Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | IBRX-042 |
Synonyms | |
Therapy Description |
IBRX-042 is a cancer vaccine comprising an adenoviral vector engineered to express HPV16-derived E6 and E7 proteins, which potentially induces a cytotoxic T-lymphocyte (CTL) response against HPV16 E6 and E7-expressing tumor cells (NCI Drug Dictionary). |